778 related articles for article (PubMed ID: 17550976)
21. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
Horsch K; Schaller MD; Hynes NE
Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
[TBL] [Abstract][Full Text] [Related]
22. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
Roach CM; Bidne KL; Romoser MR; Ross JW; Baumgard LH; Keating AF
J Anim Sci; 2022 Jul; 100(7):. PubMed ID: 35772766
[TBL] [Abstract][Full Text] [Related]
23. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
Coss D; Kuo CB; Yang L; Ingleton P; Luben R; Walker AM
Endocrinology; 1999 Nov; 140(11):5087-94. PubMed ID: 10537136
[TBL] [Abstract][Full Text] [Related]
24. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
Gao J; Hughes JP; Auperin B; Buteau H; Edery M; Zhuang H; Wojchowski DM; Horseman ND
Mol Endocrinol; 1996 Jul; 10(7):847-56. PubMed ID: 8813725
[TBL] [Abstract][Full Text] [Related]
25. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
Slattery ML; Lundgreen A; Kadlubar SA; Bondurant KL; Wolff RK
Mol Carcinog; 2013 Feb; 52(2):155-66. PubMed ID: 22121102
[TBL] [Abstract][Full Text] [Related]
26. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
Lee C; Lim HK; Sakong J; Lee YS; Kim JR; Baek SH
Mol Pharmacol; 2006 Mar; 69(3):1041-7. PubMed ID: 16354768
[TBL] [Abstract][Full Text] [Related]
27. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
28. Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.
Aksamitiene E; Achanta S; Kolch W; Kholodenko BN; Hoek JB; Kiyatkin A
Cell Signal; 2011 Nov; 23(11):1794-805. PubMed ID: 21726627
[TBL] [Abstract][Full Text] [Related]
29. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
Acosta JJ; Muñoz RM; González L; Subtil-Rodríguez A; Dominguez-Caceres MA; García-Martínez JM; Calcabrini A; Lazaro-Trueba I; Martín-Pérez J
Mol Endocrinol; 2003 Nov; 17(11):2268-82. PubMed ID: 12907754
[TBL] [Abstract][Full Text] [Related]
30. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
Paukku K; Valgeirsdóttir S; Saharinen P; Bergman M; Heldin CH; Silvennoinen O
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
32. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.
Sakamoto K; Creamer BA; Triplett AA; Wagner KU
Mol Endocrinol; 2007 Aug; 21(8):1877-92. PubMed ID: 17519353
[TBL] [Abstract][Full Text] [Related]
33. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
Zeng KW; Wang S; Dong X; Jiang Y; Jin HW; Tu PF
Toxicol Appl Pharmacol; 2014 Mar; 275(3):244-56. PubMed ID: 24486434
[TBL] [Abstract][Full Text] [Related]
34. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
[TBL] [Abstract][Full Text] [Related]
35. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
[TBL] [Abstract][Full Text] [Related]
36. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
37. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
Wu W; Coss D; Lorenson MY; Kuo CB; Xu X; Walker AM
Biochemistry; 2003 Jun; 42(24):7561-70. PubMed ID: 12809512
[TBL] [Abstract][Full Text] [Related]
38. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
Prigent-Tessier A; Barkai U; Tessier C; Cohen H; Gibori G
Endocrinology; 2001 Mar; 142(3):1242-50. PubMed ID: 11181541
[TBL] [Abstract][Full Text] [Related]
39. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
